Influenza gets help from gum disease bacteria
Scientists know that bacteria in the respiratory tract, such as specific Staphylococcus aureus strains, can boost influenza infectivity by supplying a protease that cleaves the viral spike protein hemagglutinin, a step that facilitates viral host entry. The bacterium Porphyromonas gingivalis causes periodontal disease and has been associated with severe cases of influenza, but scientists have not determined whether this connection involves hemagglutinin cleavage by a specific enzyme. In a recent from the Journal of Biological Chemistry, Noriaki Kamio and a team at Nihon University in Japan investigated the link between P. gingivalis and influenza infectivity.

The authors used immunofluorescence microscopy and a canine kidney cell line to determine that an element in the supernatant of P. gingivalis culture enhanced cell-to-cell spread of influenza, similar to cells treated with trypsin protease. The researchers hypothesized that the supernatant contains a protease that can cleave viral hemagglutinin. They suspected that the gingipain cysteine proteases Rgp and Kgp produced by P. gingivalis could perform this function.
They tested the involvement of each protease by adding individual inhibitors of Rgp and Kgp to the supernatant and found that only the Rgp inhibitor blocked hemagglutinin cleavage. In addition, the authors showed that supernatant from a P. gingivalis strain lacking Rgp could not cleave hemagglutinin. They also performed a plaque assay to measure viral titers and found that the viral concentration was lower when cells were incubated with the bacterial strain missing Rgp. Therefore, they concluded that Rgp likely cleaves hemagglutinin and enhances viral replication.
The authors suggested that future studies using human respiratory cells and animal models will help unravel details of how P. gingivalis strengthens influenza infectivity. These results may help scientists pinpoint proteins in other bacteria that may promote respiratory viral spread.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Understanding the roles of extracellular matrix and vesicles in valvular disease
MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.

Sex and diet shape fat tissue lipid profiles in obesity
Researchers found that sex hormone levels and diet both influence inflammation and lipid composition in obesity.

Mapping the placenta鈥檚 hormone network
Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.